スマート生検装置の世界市場レポート 2024年

スマート生検装置の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には6.5%の年間複合成長率（CAGR）で37億8,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、個別化医療の拡大、画像診断法の進歩、バイオマーカー分析のための生検の増加、市場への新規参入企業の参入、とデータ接続の強化に起因すると考えられます。予測期間中に予想される主要な動向には、ロボット支援生検、AI駆動生検支援、ワイヤレス生検ツールの開発、ポータブルとハンドヘルド装置の出現、リアルタイムガイダンスシステムの実装が含まれます。

スマート生検装置市場の成長は、がんの発生率の増加によって促進されると予想されます。がんは、制御されない細胞増殖を特徴とする多様な疾患群であり、精密な組織サンプルに対する需要が高まっています。これにより、がん治療の診断と計画を支援する、分子機能、画像処理機能、精密機能が強化されたスマート生検機器の開発と進歩が促進されました。特に、2022年10月、オーストラリア保健福祉研究所は、オーストラリアで新たにがんと診断される症例が増加し、2020年の154万人に比べて2021年には158万人に達したと報告しました。

低侵襲処置の採用は、スマート生検装置市場の成長に大きく貢献する態勢が整っています。身体の正常な構造への破壊を最小限に抑えるように設計された低侵襲手順では、スマート生検装置を使用して組織サンプリングの精度と精度を向上させることができます。これらの機器にはリアルタイムの超音波やMRIガイダンスなどの高度な画像技術が組み込まれていることが多く、これにより医療専門家はより小さな切開で特定の領域を対象に生検を行うことができます。これにより、患者の外傷が軽減され、診断の精度が向上します。たとえば、2023年10月の経済協力開発機構のデータによると、チェコ共和国における白内障手術件数は8.4%増加し、2021年の13万1,612件と比較して2022年の合計14万2,670件となった。手順はスマート生検装置市場の原動力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界のスマート生検装置市場の促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のスマート生検装置の市場規模実績と成長、2018～2023年
• 世界のスマート生検装置市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界のスマート生検装置市場、製品別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 針ベースの生検器具
• 施術トレイ
• ローカリゼーションワイヤー
• その他
• 世界のスマート生検装置市場、ガイダンス技術別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 超音波ガイド下生検
• 定位誘導生検
• 磁気共鳴画像法による生検
• その他
• 世界のスマート生検装置市場、用途別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 乳がん
• 皮膚がん
• 肝臓がん
• 前立腺がん
• その他
• 世界のスマート生検装置市場、エンドユーザー別セグメンテーション、実績と予測、2018～2023年、2023～2028年、2033年
• 病院
• 学術研究機関
• 診断と画像センター

第7章 地域と国の分析

• 世界のスマート生検装置市場、地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界のスマート生検装置市場、国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• スマート生検装置市場の競合情勢
• スマート生検装置市場の企業プロファイル
  • Cardinal Health Inc
  • General Electric Company
  • Medtronic Plc
  • Danaher Corporation
  • Canon Medical Systems Corporation

第31章 その他の大手と革新的な企業

• Toshiba Corporation
• Siemens Healthineers
• FUJIFILM Holdings Corporation
• Koninklijke Philips NV
• Becton Dickinson and Company
• Boston Scientific Corporation
• B. Braun Melsungen AG
• Olympus Corporation
• Intuitive Surgical Inc.
• Hologic Inc.
• Cook Medical Inc.
• CONMED Corporation
• Leica Biosystems
• Argon Medical Devices Inc.
• Esaote SpA

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在性分析

第36章 付録

Smart biopsy devices are intelligent instruments designed to enhance the precision and efficiency of tissue sampling during medical procedures, often incorporating features such as image guidance, real-time feedback, or robotic assistance. These devices aim to improve diagnostic capabilities and patient outcomes, particularly in the context of cancer diagnosis and drug delivery.

The primary products within the category of smart biopsy devices include needle-based biopsy instruments, procedure trays, localization wires, and others. Needle-based biopsy instruments are tools used to extract a sample of the body's cells for laboratory analysis, collecting tissue or liquid samples from various organs such as bones, muscles, liver, and lungs. These devices employ guidance techniques such as ultrasound-guided biopsy, stereotactic-guided biopsy, magnetic resonance imaging-guided biopsy, and others. Smart biopsy devices find applications in various areas, including breast cancer, skin cancer, liver cancer, prostate cancer, and more. The end users of these devices include hospitals, academic and research institutes, as well as diagnostic and imaging centers.

The smart biopsy devices research report is one of a series of new reports from The Business Research Company that provides smart biopsy devices market statistics, including the smart biopsy devices industry's global market size, regional shares, competitors with smart biopsy devices market share, detailed smart biopsy devices market segments, market trends and opportunities, and any further data you may need to thrive in the smart biopsy devices industry. This smart biopsy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The smart biopsy devices market size has grown strongly in recent years. It will grow from $2.73 billion in 2023 to $2.93 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth observed in the historical period can be attributed to factors such as the increased incidence of cancer cases, a growing demand for minimally invasive procedures, innovations in medical devices, and improvements in diagnostic accuracy.

The smart biopsy devices market size is expected to see strong growth in the next few years. It will grow to $3.78 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The anticipated growth in the forecast period can be attributed to the expansion of personalized medicine, advancements in imaging modalities, an increase in biopsies for biomarker analysis, the entry of new players into the market, and enhanced data connectivity. Key trends expected in the forecast period encompass robot-assisted biopsies, AI-driven biopsy assistance, the development of wireless biopsy tools, the emergence of portable and handheld devices, and the implementation of real-time guidance systems.

The growth of the smart biopsy devices market is anticipated to be propelled by the increasing incidence of cancer. Cancer, a diverse group of diseases characterized by uncontrolled cell growth, has led to a rising demand for precise tissue samples. This has stimulated the development and advancement of smart biopsy instruments equipped with enhanced molecular, imaging, and precision capabilities to aid in the diagnosis and planning of cancer treatment. Notably, in October 2022, the Australian Institute of Health and Welfare reported a rise in newly diagnosed cancer cases in Australia, reaching 1.58 million in 2021, compared to 1.54 million in 2020. Hence, the upsurge in cancer cases is a driving force behind the growth of the smart biopsy device market.

The adoption of minimally invasive procedures is poised to contribute significantly to the growth of the smart biopsy devices market. Minimally invasive procedures, designed to minimize disruption to the body's normal structures, benefit from the use of smart biopsy devices to enhance precision and accuracy in tissue sampling. These devices often incorporate advanced imaging technologies such as real-time ultrasound or MRI guidance, enabling healthcare professionals to target specific areas for biopsy through smaller incisions. This reduces patient trauma and enhances diagnostic accuracy. For instance, data from the Organization for Economic Co-operation and Development in October 2023 revealed an 8.4% increase in cataract surgical procedures in the Czech Republic, totaling 142,670 procedures in 2022 compared to 131,612 in 2021. Therefore, the growing adoption of minimally invasive procedures is a driving factor in the smart biopsy devices market.

Technological innovation has become a prominent trend in the smart biopsy devices market, with major companies focusing on developing innovative products to strengthen their market positions. An example is the launch of the Quick-Core Auto Biopsy System by IZI Medical Products LLC in April 2021. This fully automatic biopsy system enhances the efficiency and reliability of soft tissue biopsies, maintaining the high standards set by IZI's semi-automatic Quick-Core biopsy device. The portable system is lightweight and compact, allowing for one-handed use during procedures.

Major companies in the smart biopsy devices market are introducing new products, such as dual-stage core biopsy instruments, to gain a competitive advantage. Dual-stage core biopsy involves a two-step process, starting with the acquisition stage, where the biopsy instrument is guided to obtain a tissue sample, followed by the extraction stage to retrieve the obtained tissue for diagnostic analysis. For instance, Mammotome, a breast cancer care solutions company, launched the Mammotome DualCore Dual Stage Core Biopsy System in August 2022. This advanced system offers three programmable firing modes and one-handed operation, providing clinicians with a versatile tool for accessing challenging lesions. The system's ergonomic design minimizes needle movements and vibrations, enhancing the overall patient experience.

In June 2023, Quest Diagnostics, a medical laboratories company, acquired Haystack Oncology for $450 million. This strategic acquisition enhances Quest Diagnostics' cancer diagnostics portfolio by incorporating Haystack's highly sensitive minimal-residual disease (MRD) testing technology based on circulating tumor DNA (ctDNA). The addition of Haystack's advanced testing capabilities allows Quest to offer improved early detection of solid tumor cancers through blood-based clinical lab services, starting in 2024. Haystack Oncology Inc. specializes in developing and utilizing advanced technologies for MRD testing in the field of cancer diagnostics.

Major companies operating in the smart biopsy devices market report are Cardinal Health Inc., General Electric Company, Medtronic PLC, Danaher Corporation, Canon Medical Systems Corporation, Toshiba Corporation, Siemens Healthineers, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Becton Dickinson and Company, Boston Scientific Corporation, B. Braun AG, Olympus Corporation, Intuitive Surgical Inc., Hologic Inc., Cook Medical Inc., CONMED Corporation, Leica Biosystems, Argon Medical Devices Inc., Esaote SpA, SOMATEX Medical Technologies GmbH, Planmed Oy, TSK Laboratory Europe B.V., ZAMAR CARE, DTR Medical Ltd., INRAD Inc., Sterylab Srl, EndoMed Systems GmbH

North America was the largest region in the smart biopsy devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the smart biopsy devices market report during the forecast period. The regions covered in the smart biopsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the smart biopsy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smart biopsy devices market consists of revenues earned by entities by providing services such as collecting biopsy samples, real-time cancer tissue characterization, minimally invasive biopsy, and precise tissue targeting. The market value includes the value of related goods sold by the service provider or included within the service offering. The smart biopsy devices market also includes sales of image-guided biopsy devices, core biopsy devices, bone biopsy needles and devices, and molecular biopsy devices which are used in providing collecting biopsy samples, real-time cancer tissue characterization services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smart Biopsy Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smart biopsy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smart biopsy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The smart biopsy devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Needle-Based Biopsy Instruments; Procedure trays; Localization Wires; Other Products
• 2) By Guidance Technique: Ultrasound-Guided Biopsy; Stereotactic-Guided Biopsy; Magnetic Resonance Imaging-Guided Biopsy; Other Guidance Techniques
• 3) By Application: Breast Cancer; Skin Cancer; Liver Cancer; Prostate Cancer; Other Applications
• 4) By End-User: Hospitals; Academic And Research Institutes; Diagnostic And Imaging Centers
• Companies Mentioned: Cardinal Health Inc; General Electric Company; Medtronic Plc; Danaher Corporation; Canon Medical Systems Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Smart Biopsy Devices Market Characteristics

3. Smart Biopsy Devices Market Trends And Strategies

4. Smart Biopsy Devices Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Smart Biopsy Devices Market Size and Growth

• 5.1. Global Smart Biopsy Devices Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Smart Biopsy Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Smart Biopsy Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Smart Biopsy Devices Market Segmentation

• 6.1. Global Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Needle-Based Biopsy Instruments
• Procedure trays
• Localization Wires
• Other Products
• 6.2. Global Smart Biopsy Devices Market, Segmentation By Guidance Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Ultrasound-Guided Biopsy
• Stereotactic-Guided Biopsy
• Magnetic Resonance Imaging-Guided Biopsy
• Other Guidance Techniques
• 6.3. Global Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Breast Cancer
• Skin Cancer
• Liver Cancer
• Prostate Cancer
• Other Applications
• 6.4. Global Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Academic And Research Institutes
• Diagnostic And Imaging Centers

7. Smart Biopsy Devices Market Regional And Country Analysis

• 7.1. Global Smart Biopsy Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Smart Biopsy Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Smart Biopsy Devices Market

• 8.1. Asia-Pacific Smart Biopsy Devices Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Smart Biopsy Devices Market

• 9.1. China Smart Biopsy Devices Market Overview
• 9.2. China Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Smart Biopsy Devices Market

• 10.1. India Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Smart Biopsy Devices Market

• 11.1. Japan Smart Biopsy Devices Market Overview
• 11.2. Japan Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Smart Biopsy Devices Market

• 12.1. Australia Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Smart Biopsy Devices Market

• 13.1. Indonesia Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Smart Biopsy Devices Market

• 14.1. South Korea Smart Biopsy Devices Market Overview
• 14.2. South Korea Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Smart Biopsy Devices Market

• 15.1. Western Europe Smart Biopsy Devices Market Overview
• 15.2. Western Europe Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Smart Biopsy Devices Market

• 16.1. UK Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Smart Biopsy Devices Market

• 17.1. Germany Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Smart Biopsy Devices Market

• 18.1. France Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Smart Biopsy Devices Market

• 19.1. Italy Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Smart Biopsy Devices Market

• 20.1. Spain Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Smart Biopsy Devices Market

• 21.1. Eastern Europe Smart Biopsy Devices Market Overview
• 21.2. Eastern Europe Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Smart Biopsy Devices Market

• 22.1. Russia Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Smart Biopsy Devices Market

• 23.1. North America Smart Biopsy Devices Market Overview
• 23.2. North America Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Smart Biopsy Devices Market

• 24.1. USA Smart Biopsy Devices Market Overview
• 24.2. USA Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Smart Biopsy Devices Market

• 25.1. Canada Smart Biopsy Devices Market Overview
• 25.2. Canada Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Smart Biopsy Devices Market

• 26.1. South America Smart Biopsy Devices Market Overview
• 26.2. South America Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Smart Biopsy Devices Market

• 27.1. Brazil Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Smart Biopsy Devices Market

• 28.1. Middle East Smart Biopsy Devices Market Overview
• 28.2. Middle East Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Smart Biopsy Devices Market

• 29.1. Africa Smart Biopsy Devices Market Overview
• 29.2. Africa Smart Biopsy Devices Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Smart Biopsy Devices Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Smart Biopsy Devices Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Smart Biopsy Devices Market Competitive Landscape And Company Profiles

• 30.1. Smart Biopsy Devices Market Competitive Landscape
• 30.2. Smart Biopsy Devices Market Company Profiles
  • 30.2.1. Cardinal Health Inc
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. General Electric Company
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Medtronic Plc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Danaher Corporation
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Canon Medical Systems Corporation
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Smart Biopsy Devices Market Other Major And Innovative Companies

• 31.1. Toshiba Corporation
• 31.2. Siemens Healthineers
• 31.3. FUJIFILM Holdings Corporation
• 31.4. Koninklijke Philips N.V.
• 31.5. Becton Dickinson and Company
• 31.6. Boston Scientific Corporation
• 31.7. B. Braun Melsungen AG
• 31.8. Olympus Corporation
• 31.9. Intuitive Surgical Inc.
• 31.10. Hologic Inc.
• 31.11. Cook Medical Inc.
• 31.12. CONMED Corporation
• 31.13. Leica Biosystems
• 31.14. Argon Medical Devices Inc.
• 31.15. Esaote SpA

32. Global Smart Biopsy Devices Market Competitive Benchmarking

33. Global Smart Biopsy Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Smart Biopsy Devices Market

35. Smart Biopsy Devices Market Future Outlook and Potential Analysis

• 35.1 Smart Biopsy Devices Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Smart Biopsy Devices Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Smart Biopsy Devices Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer